White Blood Cell count can predict Covid 19 severity: Study
(No Ratings Yet)
Loading...
A COVID-19 diagnosis is no longer as frightening as it used to be, thanks to developments in treatment choices. However, a new study reveals that leukocyte (white blood cell) count may now be used to identify who is more likely to develop more significant disease symptoms.
“As the authors highlight, post-acute sequelae of severe acute respiratory coronavirus 2 infection significantly affects quality of life, often leading to severe disability. This effect is particularly pronounced in women, who already experience higher rates of cognitive impairments after menopause. By understanding underlying factors, we can better address these challenges and work to mitigate the cascade of symptoms that follow,” says Dr Monica Christmas, associate medical director for The Menopause Society.
Millions of people worldwide suffer from the ongoing effects of Covid-19–which is caused by the SARs-CoV-2 virus–even months after the initial diagnosis. Cognitive impairment and fatigue are the most common lingering symptoms, with cognitive impairment affecting 70per cent of patients. Older adults–especially women–are the most at risk.
Although healthcare professionals know a lot more about Covid-19 than they did at the start of the pandemic in 2020, there are still many lingering questions regarding its effect on the human body. Although it is primarily a respiratory disease, sustained effects on multiple organ systems have been documented. Previous studies have shown an excessive immune response to a Covid-19 infection.
